Comparing watchful waiting with immediate treatment for head and neck tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial compares two approaches for people with a rare type of head and neck tumor called a paraganglioma: closely watching it without immediate treatment (active follow-up) versus starting treatment right away. The goal is to see which approach better preserves your daily functioning and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a carotid or vagal head and neck paraganglioma (a rare, usually non-cancerous tumor) that is more than 10 mm in size.
- The diagnosis was confirmed by an MRI or CT scan within the last 6 months.
- Your case has been reviewed and approved by a team of specialists.
- You are being followed at a specialized reference center.
- You have only one head and neck tumor, no signs of aggressive behavior (like nerve weakness or spread), and no excess hormone production.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at the experiences of people who have been treated with a special type of radiation therapy, called PRRT, for rare tumors like pheochromocytoma or paraganglioma. It aims to learn how well the treatment worked and how long its effects lasted, to improve future care for others.
This study looks at people who have been newly diagnosed with pheochromocytoma/paraganglioma (PPGL), those with a past history of PPGL, or those with genetic risk for it. It may help doctors better evaluate and understand PPGL using specific tests.
This trial tests an oral drug called ONC206 (JZP3507) for people with advanced pheochromocytoma or paraganglioma that cannot be removed with surgery. It may be an option if you've already tried standard treatments or cannot take them.
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
This trial tests a new way of managing advanced nasopharyngeal cancer that has spread to the neck after radiation therapy. It uses regular imaging and exams to guide a less invasive neck surgery, aiming to remove any remaining cancer while preserving healthy tissue.
This study looks at how the immune system responds to rare adrenal or nerve-related tumors (pheochromocytoma and paraganglioma). Researchers want to understand the tumor's environment, which may help improve future treatments.
Hear when a new Paragangliomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.